NewGenIvf Swings to $8.0M H1 Loss as Derivative and Forbearance Charges Mount
NIVF sits 65% above its 52-week low of $0.064 on elevated volume (6.6× avg).
Summary
NewGenIvf reported an $8.0 million net loss for H1 2026, reversing a $0.7 million profit a year ago, with cash of only $1.0 million against $10.7 million in liabilities.
Key Events · Earnings and Guidance · NIVF
-
H1 2026 Net Loss of $8.0M
Net loss attributable to shareholders was $8,035,306 for the six months ended June 30, 2026, versus net income of $724,975 in the prior-year period.
-
Derivative and Forbearance Charges
Other expenses swung to a $3,990,911 loss from a $4,062,303 gain a year earlier, driven by a $710,536 embedded derivative liability and a new $6,881,250 Repurchase Forbearance liability.
-
Cash Position of $1.0M
Cash and cash equivalents were $1,023,789 as of June 30, 2026, against total liabilities of $10,723,608, including $1,104,543 in current convertible notes.
-
EPS Collapse to $(26.64)
Basic loss per share was $(26.64) for H1 2026, compared to earnings of $1,418.76 per share in H1 2025, reflecting both the loss and the retrospective reverse-split adjustments.
Analysis · NIVF · Industrial Applications And Services
NewGenIvf's first-half 2026 results reveal a sharp deterioration: a net loss of $8.0 million versus a $0.7 million profit a year earlier. The swing is driven by a $4.0 million 'other expenses' charge — largely the embedded derivative liability and a new $6.9 million Repurchase Forbearance liability tied to the June convertible note repurchase program — plus a $0.5 million interest expense. Cash stands at just $1.0 million against $10.7 million in total liabilities, leaving the company heavily reliant on the deeply dilutive financings it has been executing since September. The results land the same day the company announced its second reverse split in six weeks, underscoring the financial strain.
How filings like this one have moved
In the 30 days to Oct 7, 2026, 36.1% of the 1056 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.59%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, NIVF was trading at $0.11 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $239.1K. The 52-week trading range was $0.06 to $1,539.00. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.